Encephalomyelitis, Venezuelan Equine: Clinical Trials

8 trials for Encephalomyelitis, Venezuelan Equine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 completed, 2 not yet recruiting, 1 withdrawn. 5 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 2, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 23Unknown 2, Not yet recruiting 1

Follow Encephalomyelitis, Venezuelan Equine: new trials by email Literature Review of Encephalomyelitis, Venezuelan Equine trials Research Report on Encephalomyelitis, Venezuelan Equine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers
V4020 - Venezuelan Equine Encephalitis, Venezuelan Equine Encephalitis Virus Infection
Phase 1Not yet recruitingMedigen, Inc.392025-08-152025-07-28
Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults
0.5 mL Inactivated, Dried, C-84, TSI-GSD 205, Lot 7, Run 1 - Venezuelan Equine Encephalomyelitis
Phase 2Not yet recruitingU.S. Army Medical Research and Development Command5002021-06-012021-02-16
VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults
VRC-WEVVLP073-00-VP, VRC-GENMIX083-AL-VP - Venezuelan Equine Encephalitis, Western Equine Encephalitis
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)302019-04-022021-03-24
Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine
Vaccinations on Day 0, Day 28, and Day 140 - Encephalitis, Encephalitis, Viral
Phase 1UnknownSRI International482018-07-172021-02-23
Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers
Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate, 0.9% saline placebo - Venezuelan Equine Encephalitis Virus Infection
Phase 1CompletedIchor Medical Systems Incorporated422013-12-012015-08-26
Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83
VEE C-84 - Venezuelan Equine Encephalomyelitis
Phase 2UnknownU.S. Army Medical Research and Development Command5002008-03-012021-02-11
Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine
VEE TC-83 - Venezuelan Equine Encephalomyelitis
Phase 2UnknownU.S. Army Medical Research and Development Command5002007-09-012021-02-11
Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine
VEE 3526 - Venezuelan Equine Encephalitis
Phase 1WithdrawnDynPort Vaccine Company LLC, A GDIT Company2005-07-012015-09-18

Narrower conditions

Alphavirus Infections (3)  ·  Encephalitis (2)  ·  Nervous System Diseases (2)  ·  Virus Diseases (2)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Infections (1)  ·  Central Nervous System Viral Diseases (1)  ·  Encephalitis, Viral (1)  ·  Encephalomyelitis (1)  ·  Encephalomyelitis, Eastern Equine (1)  ·  Encephalomyelitis, Equine (1)  ·  Encephalomyelitis, Western Equine (1)  ·  Infectious Encephalitis (1)

Broader conditions

Arbovirus Infections (8)  ·  Encephalitis, Arbovirus (8)  ·  Infections (8)  ·  Mosquito-Borne Diseases (8)  ·  Neuroinflammatory Diseases (8)  ·  Vector Borne Diseases (8)  ·  Brain Diseases (7)  ·  Central Nervous System Diseases (7)  ·  Central Nervous System Infections (7)  ·  Central Nervous System Viral Diseases (7)  ·  Encephalitis, Viral (7)  ·  Encephalomyelitis (7)  ·  Encephalomyelitis, Equine (7)  ·  Infectious Encephalitis (7)  ·  RNA Virus Infections (7)

Interventions

Desiccation (1)  ·  aluminum sulfate (1)

Sponsors

U.S. Army Medical Research and Development Command (3)  ·  DynPort Vaccine Company LLC, A GDIT Company (1)  ·  Ichor Medical Systems Incorporated (1)  ·  Medigen, Inc. (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  SRI International (1)

Countries

United States (8)

Top investigators

Anthony Cardile, DO (1)  ·  Anthony P Cardile, DO, MAJ (1)  ·  Grace Chen, MD (1)  ·  Julie E Ledgerwood, DO (1)  ·  Ronald Reisler, MD (1)  ·  Sascha Goonewardena, MD (1)

Results publications

PMID 27206386, PMID 35568049, PMID 5063895